ArticleNPJ breast cancer2020

Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer.

Zongbi Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.